Angiotensin-converting Enzyme Inhibitors-induced Angioedema

1. Korzeniowska K, Cielewiczi A, Pawlaczyk M, Motowidlo K, Andrys-Wawrzyniak I, Jablecka A. Angioedema after angiotensin-converting enzyme inhibitors. Acta Pol Pharm. 2017;74:983-986.Search in Google Scholar

2. Cicardi M, Agostoni A. Hereditary angioedema. N Engl J Med. 1996;334:1666-1667. doi:10.1056/NEJM199606203342510.10.1056/NEJM1996062033425108628365Open DOISearch in Google Scholar

3. Sánchez-Borges M, González-Aveledo L. Angiotensin-Converting Enzyme Inhibitors and Angioedema. Allergy Asthma Immunol Res. 2010;2:195-198. doi: 10.4168/aair.2010.2.3.195.10.4168/aair.2010.2.3.195289205220592919Open DOISearch in Google Scholar

4. Lewis LM. Angioedema: etiology, pathophysiology, current and emerging therapies. J Emerg Med. 2013;45:789-796. doi: 10.1016/j.jemermed.2013.03.045.10.1016/j.jemermed.2013.03.04523992848Open DOISearch in Google Scholar

5. Bas M, Adams V, Suvorava T, Niehues T, Hoffmann TK, Kojda G. Nonallergic angioedema: role of bradykinin. Allergy 2007;62:842-56. doi: 10.1111/j.1398-9995.2007.01427.x.10.1111/j.1398-9995.2007.01427.x17620062Open DOISearch in Google Scholar

6. Banerji A. Current treatment of hereditary angioedema: An update on clinical studies. Allergy Asthma Proc. 2010;31:398-406. doi: 10.2500/aap.2010.31.3387.10.2500/aap.2010.31.338720929607Open DOISearch in Google Scholar

7. Baram M, Kommuri A, Sellers SA, Cohn JR. ACE inhibitorinduced angioedema. J Allergy Clin Immunol Pract. 2013;1:442-445. doi: 10.1016/j.jaip.2013.07.005.10.1016/j.jaip.2013.07.00524565614Open DOISearch in Google Scholar

8. Mlynarek A, Hagr A, Kost K. Angiotensin-converting enzyme inhibitor-induced unilateral tongue angioedema. Otolaryngol Head Neck Surg. 2003;129:593-595. doi: 10.1016/S0194-59980300724-1.Search in Google Scholar

9. Miller DR, Oliveria SA, Berlowitz DR, Fincke BG, Stang P, Lillienfeld DE. Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors. Hypertension. 2008;51:1624-1630. doi: 10.1161/HYPERTENSIONAHA.108.110270.10.1161/HYPERTENSIONAHA.108.11027018413488Open DOISearch in Google Scholar

10. Cupido C, Rayner B. Life-threatening angio-oedema and death associated with the ACE inhibitor enalapril. S Afr Med J. 2007;97:244-245.Search in Google Scholar

11. Chin HL, Buchan DA. Severe angioedema after long-term use of an angiotensin-converting enzyme inhibitor. Ann Intern Med. 1990;112:312-313.10.7326/0003-4819-112-4-312_22297216Search in Google Scholar

12. Kostis JB, Kim HJ, Rusnak J, et al. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med. 2005;165:1637-1642. doi: 10.1001/archinte.165.14.1637.10.1001/archinte.165.14.163716043683Open DOISearch in Google Scholar

13. Morimoto T, Gandhi TK, Fiskio JM, et al. An evaluation of risk factors for adverse drug events associated with angiotensinconverting enzyme inhibitors. J Eval Clin Pract. 2004;10:499-509. doi: 10.1111/j.1365-2753.2003.00484.x.10.1111/j.1365-2753.2003.00484.x15482412Search in Google Scholar

14. Abbosh J, Anderson JA, Levine AB, Kupin WL. Angiotensin converting enzyme inhibitor-induced angioedema more prevalent in transplant patients. Ann Allergy Asthma Immunol. 1999;82:473-476. doi: 10.1016/S1081-1206(10)62723-8.10.1016/S1081-1206(10)62723-8Open DOISearch in Google Scholar

15. Weber MA, Messerli FH. Angiotensin-converting enzyme inhibitors and angioedema: estimating the risk. Hypertension. 2008;51:1465-1467. doi: 10.1161/HYPERTENSIONAHA.108.111393.10.1161/HYPERTENSIONAHA.108.11139318413486Open DOISearch in Google Scholar

16. Riedl M. Hereditary angioedema therapies in the United States: movement toward an international treatment consensus. Clin Ther. 2012;34:623-630. doi: 10.1016/j.clinthera.2012.02.003.10.1016/j.clinthera.2012.02.00322386830Open DOISearch in Google Scholar

17. Farkas H, Martinez-Saguer I, Bork K, et al. International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency. Allergy. 2017;72:300-313. doi: 10.1111/all.13001.10.1111/all.13001524862227503784Open DOISearch in Google Scholar

18. Betschel S, Badiou J, Binkley K, et al. Canadian hereditary angioedema guideline. Allergy Asthma Clin Immunol. 2014;10:50. doi: 10.1186/1710-1492-10-50.10.1186/1710-1492-10-50421062525352908Open DOISearch in Google Scholar

19. Bork K. An evidence based therapeutic approach to hereditary and acquired angioedema. Curr Opin Allergy Clin Immunol. 2014;14:354-362. doi: 10.1097/ACI.0000000000000082.10.1097/ACI.000000000000008224983294Open DOISearch in Google Scholar

20. Bernstein JA, Moellman JJ. Progress in the emergency management of hereditary angioedema: focus on new treatment options in the United States. Postgrad Med. 2012;124:91-100. doi: 10.3810/pgm.2012.05.2552.10.3810/pgm.2012.05.255222691903Open DOISearch in Google Scholar